New
Aduro BioTech
The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.
HQ Location
Berkeley (United States)
Founded
2000
Employees
201 - 500
Total funding raised
$359.66M
Last Funding Event
Acquired by Chinook Therapeutics, June 2020
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases.It was founded in 2000 and headquartered in Berkeley, California.